Interaction of Ritonavir-Boosted Tipranavir with Loperamide Does Not Result in Loperamide-Associated Neurologic Side Effects in Healthy Volunteers
MUKWAYA, Geoffrey, MACGREGOR, Thomas, HOELSCHER, David, HEMING, Thomas, LEGG, Daniel, KAVANAUGH, Kelli, JOHNSON, Phillip, SABO, John P, MCCALLISTER, Scott
Published in Antimicrobial Agents and Chemotherapy (01.12.2005)
Published in Antimicrobial Agents and Chemotherapy (01.12.2005)
Get full text
Journal Article
Effects of tipranavir, darunavir, and ritonavir on platelet function, coagulation, and fibrinolysis in healthy volunteers
Kort, Jens J, Aslanyan, Stella, Scherer, Joseph, Sabo, John P, Kohlbrenner, Veronika, Robinson, Patrick
Published in Current HIV research (01.06.2011)
Published in Current HIV research (01.06.2011)
Get more information
Journal Article
Steady-State Disposition of the Nonpeptidic Protease Inhibitor Tipranavir when Coadministered with Ritonavir
LINZHI CHEN, SABO, John P, VALDEZ, Hernan, PHILIP, Elsy, YANPING MAO, NORRIS, Stephen H, MACGREGOR, Thomas R, WRUCK, Jan M, GARFINKEL, Sandra, CASTLES, Mark, BRINKMAN, Amy
Published in Antimicrobial Agents and Chemotherapy (01.07.2007)
Published in Antimicrobial Agents and Chemotherapy (01.07.2007)
Get full text
Journal Article
Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open‐Label, Fixed‐Sequence, Crossover Study
Huang, Fenglei, Voelk, Claudia, Trampisch, Matthias, Rowland, Lois, Schultz, Armin, Sabo, John P.
Published in Basic & clinical pharmacology & toxicology (01.07.2018)
Published in Basic & clinical pharmacology & toxicology (01.07.2018)
Get full text
Journal Article
Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers
Sabo, John P, Lang, Benjamin, Elgadi, Mabrouk, Huang, Fenglei
Published in Antimicrobial agents and chemotherapy (01.01.2015)
Published in Antimicrobial agents and chemotherapy (01.01.2015)
Get full text
Journal Article
Contribution of Major Metabolites toward Complex Drug-Drug Interactions of Deleobuvir: In Vitro Predictions and In Vivo Outcomes
Sane, Rucha S, Ramsden, Diane, Sabo, John P, Cooper, Curtis, Rowland, Lois, Ting, Naitee, Whitcher-Johnstone, Andrea, Tweedie, Donald J
Published in Drug metabolism and disposition (01.03.2016)
Published in Drug metabolism and disposition (01.03.2016)
Get full text
Journal Article
Mass balance, metabolite profile, and in vitro-in vivo comparison of clearance pathways of deleobuvir, a hepatitis C virus polymerase inhibitor
Chen, Lin-Zhi, Sabo, John P, Philip, Elsy, Rowland, Lois, Mao, Yan, Latli, Bachir, Ramsden, Diane, Mandarino, Debra A, Sane, Rucha S
Published in Antimicrobial agents and chemotherapy (01.01.2015)
Published in Antimicrobial agents and chemotherapy (01.01.2015)
Get full text
Journal Article
Nevirapine Extended-Release Formulation Tablets in HIV-1–Infected Children—Long-term Follow-up
Anabwani, Gabriel, Königs, Christoph, Giaquinto, Carlos, Aslanyan, Stella, Sabo, John P., Morrow, J.-Scott, Feiterna-Sperling, Cornelia
Published in Clinical infectious diseases (01.08.2015)
Published in Clinical infectious diseases (01.08.2015)
Get full text
Journal Article
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis
Zeuzem, Stefan, Soriano, Vicente, Asselah, Tarik, Gane, Edward J, Bronowicki, Jean-Pierre, Angus, Peter, Lohse, Ansgar W, Stickel, Felix, Müllhaupt, Beat, Roberts, Stuart, Schuchmann, Marcus, Manns, Michael, Bourlière, Marc, Buti, Maria, Stern, Jerry O, Gallivan, John-Paul, Voss, Florian, Sabo, John P, Böcher, Wulf, Mensa, Federico J
Published in Antimicrobial agents and chemotherapy (01.02.2015)
Published in Antimicrobial agents and chemotherapy (01.02.2015)
Get full text
Journal Article
Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: in vitro and in vivo correlation
Sabo, John P, Kort, Jens, Ballow, Charles, Kashuba, Angela D M, Haschke, Manuel, Battegay, Manuel, Girlich, Birgit, Ting, Naitee, Lang, Benjamin, Zhang, Wei, Cooper, Curtis, O'Brien, Drané, Seibert, Eleanore, Chan, Tom S, Tweedie, Donald, Li, Yongmei
Published in Journal of clinical pharmacology (01.04.2015)
Published in Journal of clinical pharmacology (01.04.2015)
Get more information
Journal Article
Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir
Sabo, John P., Kort, Jens, Ballow, Charles, Haschke, Manuel, Battegay, Manuel, Fuhr, Rainard, Girlich, Birgit, Schobelock, Michael, Feifel, Ulrich, Lang, Benjamin, Li, Yongmei, Elgadi, Mabrouk
Published in Clinical infectious diseases (15.11.2014)
Published in Clinical infectious diseases (15.11.2014)
Get full text
Journal Article
Steady-state pharmacokinetics of nevirapine extended-release tablets in HIV-1-infected children and adolescents: an open-label, multiple-dose, cross-over study
Giaquinto, Carlo, Anabwani, Gabriel, Feiterna-Sperling, Cornelia, Nuttall, James, Mompati, Kgosidialwa, Königs, Christoph, Mensa, Federico J, Sabo, John P, Yong, Chan-Loi, MacGregor, Thomas R, Nguyen, Thuy, Quinson, Anne-Marie
Published in The Pediatric infectious disease journal (01.07.2014)
Published in The Pediatric infectious disease journal (01.07.2014)
Get more information
Journal Article
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Bruce, R. Douglas, Altice, Frederick L, Moody, David E, Lin, Shen-Nan, Fang, Wenfang B, Sabo, John P, Wruck, Jan M, Piliero, Peter J, Conner, Carolyn, Andrews, Laurie, Friedland, Gerald H
Published in Drug and alcohol dependence (01.12.2009)
Published in Drug and alcohol dependence (01.12.2009)
Get full text
Journal Article
Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers
Sabo, John P, Cong, Xiuyu (Julie), Kraft, Michael-Friedrich, Wallace, Lacey, Castles, Mark A, Mauss, Stefan, MacGregor, Thomas R
Published in European journal of clinical pharmacology (01.03.2011)
Published in European journal of clinical pharmacology (01.03.2011)
Get full text
Journal Article
Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity : sub-analysis from RESIST
RAFFI, Francois, BATTEGAY, Manuel, RUSCONI, Stefano, OPRAVIL, Milos, BLICK, Gary, STEIGBIGEL, Roy T, KRAFT, Michael, NEUBACHER, Dietmar, SABO, John P
Published in AIDS (London) (12.09.2007)
Published in AIDS (London) (12.09.2007)
Get full text
Journal Article
Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection
Yong, Chan-Loi, Gathe, Joseph C, Knecht, Gabriele, Orrell, Catherine, Mallolas, Josep, Podzamczer, Daniel, Trottier, Benoit, Zhang, Wei, Sabo, John P, Vinisko, Richard, Drulak, Murray, Quinson, Anne-Marie
Published in HIV clinical trials (02.11.2017)
Published in HIV clinical trials (02.11.2017)
Get more information
Journal Article
Nevirapine Extended-Release Formulation Tablets in HIV-1–Infected Children—Long-term Follow-up: Table 1
Anabwani, Gabriel, Königs, Christoph, Giaquinto, Carlos, Aslanyan, Stella, Sabo, John P., Morrow, J.-Scott, Feiterna-Sperling, Cornelia
Published in Clinical infectious diseases (01.08.2015)
Published in Clinical infectious diseases (01.08.2015)
Get full text
Journal Article
Pharmacokinetic characterization of different dose combinations of coadministered tipranavir and ritonavir in healthy volunteers
MacGregor, Thomas R, Sabo, John P, Norris, Stephen H, Johnson, Philip, Galitz, Lawrence, McCallister, Scott
Published in HIV clinical trials (01.11.2004)
Published in HIV clinical trials (01.11.2004)
Get more information
Journal Article
Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patients
Goebel, Frank D, MacGregor, Thomas R, Sabo, John P, Castles, Mark, Johnson, Philip A, Legg, Daniel, McCallister, Scott
Published in HIV clinical trials (01.01.2010)
Published in HIV clinical trials (01.01.2010)
Get more information
Journal Article